HYUNDAI BIOSCIENCE to issue CBs for funding
현대바이오
048410
Signal Score
Historical Avg Return (5d)
+0.38%
Data Coverage
100%n=2330
Risk-adjusted indicator based on 2330 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Early redemption yield: 4.0% per annum (compounded quarterly)
- • Call option interest rate: 4.0% per annum (compounded annually)
- • First early redemption date: December 23, 2027 (106.1520% redemption rate)
- • First call option exercise date: June 23, 2027 (104.0604% exercise amount)
AI Analysis Summary
HYUNDAI BIOSCIENCE CO., LTD. has decided to issue convertible bonds. The bonds feature an early redemption option for bondholders starting December 23, 2027, with a yield of 4.0% per annum. The company also retains a call option, allowing it to repurchase bonds from June 23, 2027, at an annual compounded rate of 4.0%. Specifics on the total issuance amount, conversion price, and purpose of funds are not disclosed in this report, limiting a full assessment of dilution and financial impact. The lack of these key figures makes a definitive financial impact assessment difficult, but the structured nature of the CB with both put and call options suggests a balanced approach to financing.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.